Jupiter Life Line Hospitals Ltd
Jupiter Life Line Hospitals Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
ARPOB (Average Revenue per Occupied Bed) growth is expected to be inflation-linked rather than the previous ~10% rate, as Thane and Pune are mature hospitals. Jupiter Life Line aims to expand from 3 to 6 hospitals and reach 2,500 beds in Western India over the next 4-5 years, with operating cash flows expected to fund ongoing capex and operations.
From Jupiter Life Line Hospitals Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- ARPOB (Average Revenue per Occupied Bed) growth is expected to be inflation-linked rather than the previous ~10% rate, as Thane and Pune are mature hospitals.
- Indore may see slightly higher ARPOB growth than inflation for about one more year due to case mix optimization with more tertiary care.
- Volume growth in Pune and Indore could see some increase, while volume at Thane is expected to remain stable.
- Overall volume growth had been around 10% year-on-year in IPD and OPD segments, contributing to ~17-18% revenue growth previously.
- Capacity expansions at Dombivli (250 beds) and Pune (500 beds in phases) are expected to increase bed capacity and start contributing financially within 3 years.
2 more points from Jupiter Life Line Hospitals Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Jupiter Life Line Hospitals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Significant brownfield capex initiatives undertaken during FY25, including:
- Indore facility expansion: 2 additional floors with 78 new beds and an 11-bed ICU ready for commissioning.
- Thane facility: Received approval for additional floor development subject to environmental and statutory clearances; reconfigured existing space for new operating theaters, MRI machine, cardiac cath lab, expanded daycare, chemo suites, and new OPD cluster.
- Dombivli Hospital construction progressing as planned; expected commissioning in Q1 FY27.
- New Pune hospital (500 beds) at excavation stage post-environmental clearances, construction to begin post-monsoon.
- Pune hospital capex estimated around INR500 crores (excluding land), with favorable land lease terms (10-year lease with no escalation and right to purchase post year 3).
2 more points from Jupiter Life Line Hospitals Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Jupiter Life Line Hospitals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Jupiter Life Line Hospitals Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Jupiter Life Line Hospitals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹388 Cr, net profit ₹50 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Jupiter Life Line Hospitals Ltd's management said in earlier quarters
Others in Healthcare Services this season
- 3B Blackbio (Q4 FY25)
UK subsidiary (TRUPCR Europe Limited) revenue FY 2024-25: GBP 1,287,580, a 94% increase over FY 2023-24 GBP 664,059. Key concall takeaways from 3B Blackbio DX…
- Apollo Hospitals Enterprise Ltd (Q4 FY25)
. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Shalby (Q4 FY25)
Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…
- Suraksha Diagnostic Ltd (Q4 FY25)
Volume of tests conducted has been growing at around 10% year-on-year between FY '24 and FY '25. Key concall takeaways from Suraksha Diagnostic Ltd's Q4 FY25…
Arthneeti Pro · Annual
Jupiter Life Line Hospitals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Jupiter Life Line Hospitals Ltd Q4 FY25 results?
ARPOB (Average Revenue per Occupied Bed) growth is expected to be inflation-linked rather than the previous ~10% rate, as Thane and Pune are mature hospitals. Jupiter Life Line aims to expand from 3 to 6 hospitals and reach 2,500 beds in Western India over the next 4-5 years, with operating cash flows expected to fund ongoing capex and operations.
What is Jupiter Life Line Hospitals Ltd share price analysis?
Jupiter Life Line Hospitals Ltd currently shows a neutral. The stock trades at a P/E of 54.1 with a market cap of ₹10,351 Cr. Investors should review the full earnings analysis for detailed insights.
Is Jupiter Life Line Hospitals Ltd planning capital expenditure?
Significant brownfield capex initiatives undertaken during FY25, including: - Indore facility expansion: 2 additional floors with 78 new beds and an 11-bed ICU ready for commissioning.
Keep Jupiter Life Line Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.